Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -7.64 is 109% below its 5-year average of -3.65, near the low end of its 5-year range (-7.64–-1.93).
62.04% below its 12-month average of -4.71.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.97.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
EARNINGS PER SHARE (EPS)
-7.64
EARNINGS PER SHARE (EPS) AVG TTM
-4.71
EARNINGS PER SHARE (EPS) AVG 3Y
-4.25
EARNINGS PER SHARE (EPS) AVG 5Y
-3.65
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-62.04%
CURRENT VS 3Y AVG
-79.66%
CURRENT VS 5Y AVG
-109.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Vaxcyte, Inc.
Market Cap
$9.41B
Earnings Per Share (EPS)
-7.64
TTM Avg
-4.71
3Y Avg
-4.25
5Y Avg
-3.65
Market Cap
$9.27B
Earnings Per Share (EPS)
N/A
TTM Avg
0.30
3Y Avg
1.38
5Y Avg
1.40
Market Cap
$9.56B
Earnings Per Share (EPS)
7.98
TTM Avg
5.10
3Y Avg
1.28
5Y Avg
0.05
Market Cap
$9.64B
Earnings Per Share (EPS)
3.43
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
Market Cap
$9.00B
Earnings Per Share (EPS)
-3.75
TTM Avg
-4.83
3Y Avg
-4.88
5Y Avg
-4.31
Market Cap
$8.98B
Earnings Per Share (EPS)
N/A
TTM Avg
0.30
3Y Avg
1.38
5Y Avg
1.40
Market Cap
$9.99B
Earnings Per Share (EPS)
8.25
TTM Avg
-18.74
3Y Avg
-45.28
5Y Avg
14.90
Market Cap
$8.80B
Earnings Per Share (EPS)
1.03
TTM Avg
1.21
3Y Avg
-0.37
5Y Avg
-1.01
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.41B | -7.64 | -4.71 | -4.25 | -3.65 |
| Insulet Corp. (PODD)vs › | $9.36B | 5.35 | 4.74 | 3.13 | 2.14 |
| Bruker Corporation (BRKR)vs › | $9.27B | N/A | 0.30 | 1.38 | 1.40 |
| Krystal Biotech, Inc. (KRYS)vs › | $9.56B | 7.98 | 5.10 | 1.28 | 0.05 |
| Henry Schein, Inc. (HSIC)vs › | $9.64B | 3.43 | 3.18 | 3.37 | 3.47 |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.00B | -3.75 | -4.83 | -4.88 | -4.31 |
| Bruker Corporation (BRKRP)vs › | $8.98B | N/A | 0.30 | 1.38 | 1.40 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.99B | 8.25 | -18.74 | -45.28 | 14.90 |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.80B | 1.03 | 1.21 | -0.37 | -1.01 |
| Repligen Corporation (RGEN)vs › | $10.02B | 0.73 | 0.20 | 1.10 | 1.31 |
Trailing EPS (TTM)
$-7.64
Forward EPS (Est.)
$-8.27
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -5.63 |
| 2024-12-31 | -3.80 |
| 2023-12-31 | -4.14 |
| 2022-12-31 | -3.44 |
| 2021-12-31 | -1.93 |
| 2020-12-31 | -2.97 |
| 2019-12-31 | -14.10 |
| 2018-12-31 | -8.12 |
| 2017-12-31 | -4.84 |
